[ Back to EurekAlert! ]

PUBLIC RELEASE DATE:
16-Dec-2013

[ | E-mail ] Share Share

Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News

Blue light phototherapy kills antibiotic-resistant bacteria, according to new studies

IMAGE: Photomedicine and Laser Surgery is published online 12 times per year. For more information visit www.liebertpub.com/pho....

Click here for more information.

New Rochelle, NY, December16, 2013--Blue light has proven to have powerful bacteria-killing ability in the laboratory. The potent antibacterial effects of irradiation using light in the blue spectra have now also been demonstrated in human and animal tissues. A series of groundbreaking articles that provide compelling evidence of this effect are published in Photomedicine and Laser Surgery, a peer-reviewed journal published by Mary Ann Liebert, Inc., publishers. The articles are available on the Photomedicine and Laser Surgery website.

"Bacterial resistance to drugs poses a major healthcare problem," says Co-Editor-in-Chief Chukuka S. Enwemeka, PhD, Dean, College of Health Sciences, University of Wisconsin--Milwaukee, in the accompanying Editorial "Antimicrobial Blue Light: An Emerging Alternative to Antibiotics," citing the growing number of deadly outbreaks worldwide of methicillin-resistant Staphylococcus aureus (MRSA). The articles in this issue of Photomedicine and Laser Surgery provide evidence that "blue light in the range of 405-470 nm wavelength is bactericidal and has the potential to help stem the ongoing pandemic of MRSA and other bacterial infections."

In the article "Effects of Photodynamic Therapy on Gram-Positive and Gram-Negative Bacterial Biofilms by Bioluminescence Imaging and Scanning Electron Microscopic Analysis," Aguinaldo S. Garcez, PhD and coauthors show that photodynamic therapy and methylene blue delivered directly into the root canal of a human tooth infected with a bacterial biofilm was able to destroy both Gram-positive and Gram-negative bacteria, disrupt the biofilms, and reduce the number of bacteria adhering to the tooth.

Raymond J. Lanzafame, MD, MBA, and colleagues demonstrated significantly greater bacterial reduction in the treatment of pressure ulcers in mice using a combination of photoactivated collagen-embedded compounds plus 455 nm diode laser irradiation compared to irradiation alone or no treatment. The antibacterial effect of the combined therapy increased with successive treatments, report the authors in the article "Preliminary Assessment of Photoactivated Antimicrobial Collagen on Bioburden in a Murine Pressure Ulcer Model."

In the article "Wavelength and Bacterial Density Influence the Bactericidal Effect of Blue Light on Methicillin-Resistant Staphylococcus aureus (MRSA)," Violet Bumah, PhD and coauthors compared the bacteria-killing power of 405 nm versus 470 nm light on colonies of resistant Staph aureus and how the density of the bacterial colonies could limit light penetration and the bactericidal effects of treatment.

###

About the Journal

Photomedicine and Laser Surgery is an authoritative peer-reviewed online journal published monthly. The Journal is under the leadership of Editor-in-Chief Raymond J. Lanzafame, MD, MBA and Co-Editor-in-Chief Chukuka S. Enwemeka, PhD. The Journal provides rapid publication of cutting-edge techniques and research in phototherapy, low level laser therapy (LLLT), and laser medicine and surgery. Reports cover a range of basic and clinical research and procedures in medicine, surgery, and dentistry, focusing on safety issues, new instrumentation, optical diagnostics, and activities related to the understanding and applications of biophotonics in medicine. Photomedicine and Laser Surgery is the official journal of the World Association for Laser Therapy (WALT), North American Association for Laser Therapy (NAALT), and an official journal of the World Federation for Laser Dentistry (WFLD) Tables of content and a free sample issue may be viewed on the Photomedicine and Laser Surgery website.

About the Publisher

Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in promising areas of science and biomedical research, including Journal of Laparoendoscopic & Advanced Surgical Techniques and Journal of Gynecologic Surgery. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.

Mary Ann Liebert, Inc.
140 Huguenot St., New Rochelle, NY 10801-5215
Phone: (914) 740-2100 (800) M-LIEBERT Fax: (914) 740-2101
http://www.liebertpub.com



[ Back to EurekAlert! ] [ | E-mail Share Share ]

 


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.